RecallDepth
Class II Terminated

Ephedrine Sulfate Injection, USP, 50 mg/mL, Single Dose Vial, packaged in a) 1 mL fill in a 2 mL Vial (NDC: 69053-008-01); and b) 25 x 2 mL Vials (NDC 69053-008-02), Rx only, Manufactured for: Andersen Pharmaceutical, White Plains, NY 10605.

This recall has been terminated (originally issued September 14, 2016).

Company
Allergy Laboratories, Inc.
Recall Initiated
August 10, 2016
Posted
September 14, 2016
Recall Number
D-1498-2016
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1,928,075 vials
Firm Location
Oklahoma City, OK, United States
Official Source
View on FDA website ↗

Reason for Recall

Lack of Assurance of Sterility: An FDA inspection at the facility raised concerns that product sterility was potentially impacted.

Distribution

Nationwide

Lot / Code Info

Lot #s: 102814, 102914, 103014, 103114, Exp 10/16; 110314, 110414, 110514, 110614, 110714, 111014, Exp 11/16; 121014, 121114, 121214, 121514, Exp 12/16; 011415, 011515, 011615, 012015, 012115, Exp 01/17; 021315, 021715, 021815, 021915, 022015, Exp 02/17; 030415, 030515, 030615, 031015, 031715, Exp 03/17; 042415, 042815, 042915, 043015, Exp 04/17; 050115, 050515, 052815, 052915, Exp 05/17; 060315, 060415, 061615, 061715, Exp 06/17

More recalls by Allergy Laboratories, Inc.

View all recalls by this company →

Other recent Class II Drug recalls